Nasdaq Warns Coeptis Therapeutics Over Missed Annual Shareholder Meeting Deadline
I'm PortAI, I can summarize articles.
Coeptis Therapeutics Holdings Inc. has been notified by Nasdaq for failing to hold its annual shareholder meeting within the required timeframe, leading to noncompliance with listing rules. The company has until February 26, 2026, to submit a compliance plan, with a potential extension until June 29, 2026. Coeptis plans to hold its annual meeting on January 30, 2026, which it believes will address the compliance issue.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments